Call Us Today @ 0172-2638781, 2638782, 2638786 | info@indswift.com

 Development of NDDS (Novel Drug Delivery System).

 Development of non infringing process.

 New process development for cost effectiveness.

 Trouble shooting in the various plants .

 Performance batches.

 Bioequivalence and bioavailability as per DCGI (Drug Controller General of India) and International guidelines.

 Drug regulatory affair and documentation: Dossiers for ANDA’s( Abbreviated New Drug Application) of different countries, NDA's (New Drug Application) filing in India, patents filing after a thorough scrutiny by attorneys, documentation for getting USFDA, documentation for R & D products, documentation for commercial samples, documentation for bioequivalence samples.

 Contract Research from conceptualization till the final dossier of the product.